Bottom line
MRRGX vs SCHG: the short answer
MRRGX (Meridian Growth Fund) and SCHG (Schwab U.S. Large-Cap Growth ETF) are both mutual funds.
But SCHG is far broader, holding 197 positions to 91 for MRRGX, so beyond the top names it adds exposure MRRGX doesn't have.
SCHG is cheaper at 0.04% vs 0.92% — a difference of $88 a year per $10,000 invested.
Over five years, SCHG returned +19.7% a year vs −1.3% for MRRGX (reporting dates differ).
Updated Nov 19, 2026
MRRGX vs SCHG side by side
| MRRGX | SCHG | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Meridian | Schwab |
| Category | Large Growth | Large Growth |
| Expense ratio | 0.92% | 0.04% |
| Annual cost per $10k | $92 | $4 |
| 10-yr cost on $10k (prospectus) | $1,130 | $51 |
| Max front load | 0% | None |
| 12b-1 fee | — | — |
| 1-yr return | −6.3% | +34.9% |
| 5-yr return (annualized) | −1.3% | +19.7% |
| 10-yr return (annualized) | +7.4% | +16.7% |
| Best quarter | — | +27.7% |
| Worst quarter | — | −22.3% |
| Net assets (fund) | $542.9M | $61.1B |
| Number of holdings | 91 | 197 |
| Portfolio turnover | 49% | 27% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
MRRGX and SCHG share none of their top holdings.
MRRGX top 10
- Stit Govt And Agency Inst — 4.17%
- Rb Global Inc — 2.49%
- Curtiss-wright Corp — 2.46%
- Axogen Inc — 2.43%
- Federal Signal Corp — 2.36%
- Hinge Health Inc — 2.29%
- Definium Therapeutics Inc — 2.20%
- Veracyte Inc — 2.14%
- Standardaero Inc — 2.09%
- Turning Point Brands Inc — 2.08%
SCHG top 10
- NVIDIA Corp — 11.01%
- Apple Inc — 9.83%
- Microsoft Corp — 7.17%
- Amazon.com Inc — 5.67%
- Alphabet Inc — 4.75%
- Broadcom Inc — 4.55%
- Tesla Inc — 3.91%
- Alphabet Inc — 3.78%
- Meta Platforms Inc — 3.45%
- Eli Lilly & Co — 3.05%
FAQ
What is the difference between MRRGX and SCHG?
Which is cheaper, MRRGX or SCHG?
Should I own both MRRGX and SCHG?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.